Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse.

Blood ·Vol. 96 ·No. 4 ·2000-08-15 ·Pages 1619-20

de Haas V, Breunis WB, Verhagen OJ, van der Berg H, van der Schoot CE

Abstract

暂无摘要

MeSH Terms

Burkitt Lymphoma/genetics,pathology Humans Neoplasm, Residual/diagnosis,genetics,pathology Polymerase Chain Reaction Predictive Value of Tests Recurrence

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

de Haas V

Breunis W B

Verhagen O J

van der Berg H

van der Schoot C E

Article Info

Journal

Blood

Abbr.

Blood

ISSN

0006-4971

Published

2000-08-15

Pages

1619-20

Language

English

Region

United States

NLM ID

7603509

Subset

Corrections

CommentOn

PMID: 10648387

External Links

PubMed source View journal details

Analysis Services

Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse.

Contact

WeChat Official Account